Novartis division Alcon spinoff ousts Baer from Swiss benchmark SMI Medical Dialogues Bureau5 April 2019 9:00 AM ISTNovartis has estimated Alcon's value at around 25 billion Swiss francs ($25 billion), while some analysts predict an initial market capitalisation of...